BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE RX PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER
|
Back to Search Results |
|
Model Number U415064RX |
Device Problems
Deflation Problem (1149); Difficult to Insert (1316)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/16/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.Expiry date (01/2023).
|
|
Event Description
|
It was reported that during an angioplasty procedure, the pta balloon allegedly had difficulty being deflated and failed to be inserted at the second attempt.There was no reported patient injury.
|
|
Event Description
|
It was reported that during an angioplasty procedure, the pta balloon allegedly had difficulty being deflated and failed to be inserted at the second attempt.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.A definitive root cause could not be determined based upon the provided information.Labeling review: the review of the instructions for use, indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.H10: d4 expiry date (01/2023).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Search Alerts/Recalls
|
|
|